161 related articles for article (PubMed ID: 26408493)
1. New von Hippel-Lindau manifestations develop at the same or decreased rates in pregnancy.
Binderup ML; Budtz-Jørgensen E; Bisgaard ML
Neurology; 2015 Oct; 85(17):1500-3. PubMed ID: 26408493
[TBL] [Abstract][Full Text] [Related]
2. Retinal hemangioblastoma: prevalence, incidence and frequency of underlying von Hippel-Lindau disease.
Binderup MLM; Stendell AS; Galanakis M; Møller HU; Kiilgaard JF; Bisgaard ML
Br J Ophthalmol; 2018 Jul; 102(7):942-947. PubMed ID: 28972023
[TBL] [Abstract][Full Text] [Related]
3. A genetic register for von Hippel-Lindau disease.
Maddock IR; Moran A; Maher ER; Teare MD; Norman A; Payne SJ; Whitehouse R; Dodd C; Lavin M; Hartley N; Super M; Evans DG
J Med Genet; 1996 Feb; 33(2):120-7. PubMed ID: 8929948
[TBL] [Abstract][Full Text] [Related]
4. Surveillance in von Hippel-Lindau disease (vHL).
Poulsen ML; Budtz-Jørgensen E; Bisgaard ML
Clin Genet; 2010 Jan; 77(1):49-59. PubMed ID: 19863552
[TBL] [Abstract][Full Text] [Related]
5. von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome.
Binderup MLM
Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510814
[TBL] [Abstract][Full Text] [Related]
6. Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease.
Ye DY; Bakhtian KD; Asthagiri AR; Lonser RR
J Neurosurg; 2012 Nov; 117(5):818-24. PubMed ID: 22937928
[TBL] [Abstract][Full Text] [Related]
7. Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations.
Kruizinga RC; Sluiter WJ; de Vries EG; Zonnenberg BA; Lips CJ; van der Horst-Schrivers AN; Walenkamp AM; Links TP
Endocr Relat Cancer; 2014 Feb; 21(1):63-71. PubMed ID: 24132471
[TBL] [Abstract][Full Text] [Related]
8. The incidence of consecutive manifestations in Von Hippel-Lindau disease.
van der Horst-Schrivers ANA; Sluiter WJ; Kruizinga RC; van Leeuwaarde RS; Giles R; Olderode-Berends MJW; Links TP
Fam Cancer; 2019 Jul; 18(3):369-376. PubMed ID: 31087189
[TBL] [Abstract][Full Text] [Related]
9. Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment.
Shuin T; Yamasaki I; Tamura K; Okuda H; Furihata M; Ashida S
Jpn J Clin Oncol; 2006 Jun; 36(6):337-43. PubMed ID: 16818478
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of a Canadian cohort of von Hippel-Lindau disease patients.
Salama Y; Albanyan S; Szybowska M; Bullivant G; Gallinger B; Giles RH; Asa S; Badduke C; Chiorean A; Druker H; Ezzat S; Hannah-Shmouni F; Hernandez KG; Inglese C; Jani P; Kaur Y; Krema H; Krimus L; Laperriere N; Lichner Z; Mete O; Sit M; Zadeh G; Jewett MAS; Malkin D; Stockley T; Wasserman JD; Xu W; Schachter NF; Kim RH
Clin Genet; 2019 Nov; 96(5):461-467. PubMed ID: 31368132
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of magnetic resonance imaging findings in pancreatic and other abdominal manifestations of Von Hippel-Lindau disease in a series of 23 patients: a pictorial review.
Graziani R; Mautone S; Vigo M; Manfredi R; Opocher G; Falconi M
JOP; 2014 Jan; 15(1):1-18. PubMed ID: 24413778
[TBL] [Abstract][Full Text] [Related]
12. Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium.
Capitanio U; Rosiello G; Erdem S; Rowe I; Kara O; Roussel E; Campi R; Klatte T; Kriegmair MC; Sibona M; Bertolo R; Ouzaid I; Mir MC; Marra G; Larcher A; Montorsi F; Salonia A;
World J Urol; 2021 Aug; 39(8):2969-2975. PubMed ID: 33416974
[TBL] [Abstract][Full Text] [Related]
13. Genotype-phenotype correlation in von Hippel-Lindau disease.
Reich M; Jaegle S; Neumann-Haefelin E; Klingler JH; Evers C; Daniel M; Bucher F; Ludwig F; Nuessle S; Kopp J; Boehringer D; Reinhard T; Lagrèze WA; Lange C; Agostini H; Lang SJ
Acta Ophthalmol; 2021 Dec; 99(8):e1492-e1500. PubMed ID: 33720516
[TBL] [Abstract][Full Text] [Related]
14. [Hippel-Lindau disease].
Krzystolik K; Cybulski C; Lubiński J
Neurol Neurochir Pol; 1998; 32(5):1119-33. PubMed ID: 10463227
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
16. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.
Neumann HP; Berger DP; Sigmund G; Blum U; Schmidt D; Parmer RJ; Volk B; Kirste G
N Engl J Med; 1993 Nov; 329(21):1531-8. PubMed ID: 8105382
[TBL] [Abstract][Full Text] [Related]
17. von Hippel-Lindau development in children and adolescents.
Launbjerg K; Bache I; Galanakis M; Bisgaard ML; Binderup MLM
Am J Med Genet A; 2017 Sep; 173(9):2381-2394. PubMed ID: 28650583
[TBL] [Abstract][Full Text] [Related]
18. Risk of new tumors in von Hippel-Lindau patients depends on age and genotype.
Binderup ML; Budtz-Jørgensen E; Bisgaard ML
Genet Med; 2016 Jan; 18(1):89-97. PubMed ID: 25834951
[TBL] [Abstract][Full Text] [Related]
19. von Hippel-Lindau Disease: Review of Genetics and Imaging.
Shanbhogue KP; Hoch M; Fatterpaker G; Chandarana H
Radiol Clin North Am; 2016 May; 54(3):409-22. PubMed ID: 27153780
[TBL] [Abstract][Full Text] [Related]
20. Low frequency of VHL germline mutations in Norwegian patients presenting with isolated central nervous system hemangioblastomas--a population-based study.
Rønning P; Andresen PA; Hald JK; Heimdal K; Scheie D; Schreiner T; Helseth E
Acta Neurol Scand; 2010 Aug; 122(2):124-31. PubMed ID: 19814753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]